slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 42,301-42,330
Pages 2,019
Rows per page 30
Component
42,301-42,330 of 60,568
28
The table includes non-GAAP financial measures (Adjusted EBITDA) and adjustments for non-recurring items.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations 1 hit
29
The table includes adjustments for share-based compensation and depreciation & amortization to arrive at non-IFRS metrics.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations 1 hit
30
The table shows a consistent increase in revenue alongside rising operating expenses and operating losses.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations 1 hit
31
The table reconciles IFRS gross profit to Non-IFRS gross profit by adding back share-based compensation and depreciation & amortization.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations 1 hit
32
The table reconciles operating loss to Adjusted EBITDA by adding back non-cash and non-recurring items.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations 1 hit
33
Freightos | Investor Presentation Deck | 33 slidesFreightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations 1 hit
26
The table includes both audited and unaudited financial data, with a specific note defining the calculation methodology for Adjusted EBITDA.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · Financials1 hit
27
Genius Group | Investor Presentation Deck | 29 slidesGenius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · Financials1 hit
11
The slide uses a table to categorize recent expansions into acquisitions and greenfield openings.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations Beat · Financials1 hit
16
GMS | Investor Conference Presentation Deck | 26 slidesGMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations Beat · Financials1 hit
17
Includes footnotes regarding Adjusted EBITDA, Free Cash Flow, and Tax Rate.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations Beat · Financials1 hit
18
Includes operational metrics like business days and branch counts.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
19
Includes supplemental cash flow disclosures and a non-GAAP reconciliation for free cash flow.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
20
The table breaks down net sales by organic growth, acquisitions, and FX impact, as well as by product category (Wallboard, Ceilings, Steel Framing, Complementary Products).GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
21
Includes a commentary section explaining specific adjustment line items.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
22
The table includes a detailed breakdown of adjustments including stock appreciation rights, equity-based compensation, and acquisition-related costs.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
23
Includes footnotes A and B explaining specific adjustments.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
24
The table includes a commentary section explaining the specific adjustments (A-E).GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
25
Includes footnotes detailing adjustments for unamortized discounts and deferred financing costs.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
26
GMS | Investor Conference Presentation Deck | 26 slidesGMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
08
The slide uses a comparison table to justify a portfolio disposal strategy by showing improved quality metrics in the remaining assets.Hipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
20
The slide compares 'Pre First Disposal' vs 'Post First Disposal' metrics for Borrowing Policy and RCF LTV Covenant.Hipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations 1 hit
07
The table uses a traffic light system (green, yellow, red) to visually indicate performance across categories.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Market Size1 hit
08
The slide uses a comparison framework to contrast traditional vs. new product workflows.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Market Size1 hit
06
The slide uses a visual comparison to highlight the safety advantage of NXC-201, specifically focusing on neurotoxicity and CRS duration.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
14
The slide uses a table structure to contrast treatment outcomes and patient growth across three stages of multiple myeloma.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
16
Includes FDA approval precedents in the footer to establish credibility.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
20
The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and highlighting specific regulatory and clinical trial milestones.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
21
Combines market sizing data with a 'Why Now' narrative supported by industry news clippings and a comparative efficacy table.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Golden Circle1 hit
24
The slide uses a red dashed box to highlight the primary efficacy metrics (response rates).Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit